Neonatal transfusion practice

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 89, Issue 2, 2004, Pages

  Murray, N A ^a   Roberts, I A G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; HEMOPOIETIC GROWTH FACTOR; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT THROMBOPOIETIN;

ANEMIA; BLOOD CLOTTING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CLINICAL PRACTICE; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DILUTION; DRUG EFFECT; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FREEZING; HEMOLYSIS; HUMAN; HYPERBILIRUBINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; LACTATE BLOOD LEVEL; MEDICAL PRACTICE; NECROTIZING ENTEROCOLITIS; NEWBORN; OUTCOMES RESEARCH; PEDIATRICS; PERIPHERAL FRACTIONAL OXYGEN EXTRACTION; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; RISK FACTOR; SEPSIS; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TECHNIQUE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TISSUE OXYGENATION; TISSUE PERFUSION;

EID: 1542721751     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/adc.2002.019760     Document Type: Review

References (83)

1. Calhaun DA, Christensen RD, Edstrom CS, et al. Consistent approaches to procedures and practices in neonatal hematology. Clin Perinatol 2000;27:733-53.
2. Bednarek FJ, Weisberger S, Richardson DK, et al. Variations in blood transfusions among newborn intensive care units. SNAP II Study Group. J Pediatr 1998;133:601-7.
3. Ringer SA, Richardson DK, Sacher RA, et al. Variations in transfusion practice in neonatal intensive care. Pediatrics 1998;101:194-200.
4. Levy GJ, Strauss RG, Hume H, et al. National survey of neonatal transfusion practices. I. Red blood cell therapy. Pediatrics 1993;91:523-9.
5. Strauss RG, Levy GJ, Sotelo-Avila C, et al. National survey of neonatal transfusion practices. II. Blood component therapy. Pediatrics 1993;91:530-6.
6. Maier RF, Metze B, Obladen M. Low degree of regionalization and high transfusion rates in very low birthweight infants: a survey in Germany. J Perinat Med 1998;26:43-8.
7. Busch MP, Kleinman SH, Nemo GJ. Current and emerging infectious risks of blood transfusions. JAMA 2003;289:959-62.
8. Andreu G, Morel P, Forestier F, et al. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 2002;42:1356-64.
9. Quirolo KC. Transfusion medicine for the pediatrician. Pediatr Clin North Am 2002;49:1211-38.
10. Luban NL. Neonatal red blood cell transfusions. Curr Opin Hematol 2002;9:533-6.
11. Hume H. Red blood cell transfusions for preterm infants: the role of evidence-based medicine. Semin Perinatol 1997;21:8-19.
12. Wardle SP, Garr R, Yoxall CW, et al. A pilot randomised controlled trial of peripheral fractional oxygen extraction to guide blood transfusions in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002;86:F22-7.
13. Frey B, Losa M. The value of capillary whole blood lactate for blood transfusion requirements in anaemia of prematurity. Intensive Care Med 2001;27:222-7.
14. Wardle SP, Weindling AM. Peripheral fractional oxygen extraction and other measures of tissue oxygenation to guide blood transfusions in preterm infants. Semin Perinatol 2001;25:60-4.
15. Moller JC, Schwarz U, Schaible TF, et al. Do cardiac output and serum lactate levels indicate blood transfusion requirements in anemia of prematurity? Intensive Care Med 1996;22:472-6.
16. Izraeli S, Ben-Sira L, Harell D, et al. Lactic acid as a predictor for erythrocyte transfusion in healthy preterm infants with anemia of prematurity. J Pediatr 1993;122:629-31.
17. Beeram MR, Krauss DR, Riggs MW. Red blood cell transfusion practices in very low birth weight infants in 1990s postsurfactant era. J Natl Med Assoc 2001;93:405-9.
18. Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal Ed 2001;84:F96-100.
19. Maier RF, Sonntag J, Walka MM, et al. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr 2000;136:220-4.
20. Widness JA, Seward VJ, Kromer IJ, et al. Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 1996;129:680-7.
21. Brooks SE, Marcus DM, Gillis D, et al. The effect of blood transfusion protocol on retinopathy of prematurity: a prospective, randomized study. Pediatrics 1999;104:514-18.
22. Corwin HL, Parsonnet KC, Gettinger A. RBC transfusion in the ICU. Is there a reason? Chest 1995;108:767-71.
23. British Committee for Standards in Haematology. www.bcshguidelines.com.
24. Paul DA, Leef KH, Locke RG, et al. Transfusion volume in infants with very low birth weight: a randomized trial of 10 versus 20 ml/kg. J Pediatr Hematol Oncol 2002;24:43-6.
25. Alagappan A, Shattuck KE, Malloy MH. Impact of transfusion guidelines on neonatal transfusions. J Perinatol 1998;18:92-7.
26. Castle V, Andrew M, Kelton J, et al. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr 1986;108:749-55.
27. Mehta P, Rohitkumar V, Neumann L, et al. Thrombocytopenia in the high risk infant. J Pediatr 1980;97:791-4.
28. Amato M, Fauchere JC, Herman Jr U. Coagulation abnormalities in low birth weight infants with peri-intraventricular hemorrhage. Neuropediatrics 1988;19:154-7.
29. Andrew M, Castle V, Saigal S, et al. Clinical impact of neonatal thrombocytopenia. J Pediatr 1987;110:457-64.
30. Van De Bor M, Briet E, Van Bel F, et al. Hemostasis and periventricular-intraventricular hemorrhage of the newborn. American Journal of Diseases in Children 1986;140:1131-4.
31. Murray NA, Roberts IAG. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res 1996;40:112-19.
32. Kahn DJ, Richardson DK, Billett HH. Association of thrombocytopenia and delivery method with intraventricular hemorrhage among very-low-birth-weight infants. Am J Obstet Gynecol 2002;186:109-16.
33. Andrew M, Vegh P, Caco C, et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993;123:285-91.
34. Murray NA, Howarth LJ, McCloy MP, et al. Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients. Transfus Med 2002;12:35-41.
35. Garcia MG, Duenas E, Sola MC, et al. Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol 2001;21:415-20.
36. Del Vecchio A, Sola MC, Theriaque DW, et al. Platelet transfusions in the neonatal intensive care unit: factors predicting which patients will require multiple transfusions. Transfusion 2001;41:803-8.
37. Contreras M, Ala FA, Greaves M, et al. Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med 1992;2:57-63.
38. Northern Neonatal Nursing Initiative Trial Group. Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: outcome at 2 years. Lancet 1996;348:229-32.
39. Emery EF, Greenough A, Gamsu HR. Randomised controlled trial of colloid infusions in hypotensive preterm infants. Arch Dis Child 1992;67:1185-8.
40. Supapannachart S, Siripoonya P, Boonwattanasoontorn W, et al. Neonatal polycythemia: effects of partial exchange transfusion using fresh frozen plasma, Haemaccel and normal saline. J Med Assoc Thai 1999;82(suppl 1):S82-6.
41. Krediet TG, Beurskens FJ, van Dijk H, et al. Antibody responses and opsonic activity in sera of preterm neonates with coagulase-negative staphylococcal septicemia and the effect of the administration of fresh frozen plasma. Pediatr Res 1998;43:645-51.
42. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987;70:165-72.
43. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988;72:1651-7.
44. British Committee for Standards in Haematology Haemostasis and Thrombosis Task Force. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002;119:295-309.
45. Muntean W. Fresh frozen plasma in the pediatric age group and in congenital coagulation factor deficiency. Thromb Res 2002;107(suppl 1):S29.
46. So KW, Fok TF, Ng PC, et al. Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants. Arch Dis Child Fetal Neonatal Ed 1997;76:F43-6.
47. Greenough A, Emery E, Hird MF, et al. Randomised controlled trial of albumin infusion in ill preterm infants. Eur J Pediatr 1993;152:157-9.
48. Alderson P, Bunn F, Lefebvre C, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2002;(1):CD001208.
49. Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev 2001;(2):CD000361.
50. Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev 2001;(2):CD001239.
51. Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002;3:CD003313.
52. Gottstein R, Cooke RW. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003;88:F6-10.
53. Funato M, Tamai H, Shimada S. Trends in neonatal exchange transfusions at Yodogawa Christian Hospital. Acta Paediatr Jpn 1997;39:305-8.
54. Upadhyay A, Aggarwal R, Deorari AK, et al. Polycythemia in the newborn. Indian J Pediatr 2002;69:79-82.
55. Rothenberg T. Partial plasma exchange transfusion in polycythaemic neonates. Arch Dis Child 2002;86:60-2.
56. Merchant RH, Phadke SD, Sakhalkar VS, et al. Hematocrit and whole blood viscosity in newborns: analysis of 100 cases. Indian Pediatr 1992;29:555-61.
57. Ratrisawadi V, Plubrukarn R, Trakulchang K, et al. Developmental outcome of infants with neonatal polycythemia. J Med Assoc Thai 1994;77:76-80.
58. Drew JH, Guaran RL, Cichello M, et al. Neonatal whole blood hyperviscosity: the important factor influencing later neurologic function is the viscosity and not the polycythemia. Clin Hemorheol Microcirc 1997;17:67-72.
59. Supapannachart S, Siripoonya P, Boonwattanasoontorn W, et al. Neonatal polycythemia: effects of partial exchange transfusion using fresh frozen plasma, Haemaccel and normal saline. J Med Assoc Thai 1999;82(suppl 1):S82-6.
60. Wong W, Fok TF, Lee CH, et al. Randomised controlled trial: comparison of colloid or crystalloid for partial exchange transfusion for treatment of neonatal polycythaemia. Arch Dis Child Fetal Neonatal Ed 1997;77:F115-18.
61. Ohls RK. Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity. Paediatr Drugs 2002;4:111-21.
62. Strauss RG. Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin. Transfus Med Rev 2001;15:213-23.
63. Zipursky A. Erythropoietin therapy for premature infants: cost without benefit? Pediatr Res 2000;48:136.
64. Casadevall N, Nataf J, Viron B, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med 2002;346:469-75.
65. Maier RF, Obladen M, Muller-Hansen I, et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 2002;141:8-15.
66. Rao R, Georgieff MK. Neonatal iron nutrition. Semin Neonatol 2001;6:425-35.
67. Bechensteen AG, Haga P, Halvorsen S, et al. Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake. Eur J Pediatr 1997;156:56-61.
68. Bechensteen AG, Haga P, Halvorsen S, et al. Erythropoietín, protein, and iron supplementation and the prevention of anaemia of prematurity. Arch Dis Child 1993;69:19-23.
69. Shannon KM, Keith JF 3rd, Mentzer WC, et al. ecombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95:1-8.
70. Maier RF, Obladen M, Scigalla P, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med 1994;330:1173-8.
71. Ahmad A, Laborada G, Bussel J, et al. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants. Pediatr Infect Dis J 2002;21:1061-5.
72. Miura E, Procianoy RS, Bittar C, et al. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Pediatrics 2001;107:30-5.
73. Bedford Russell AR, Emmerson AJ, Wilkinson N, et al. A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia. Arch Dis Child Fetal Neonatal Ed 2001;84:F172-6.
74. Carr R, Modi N, Dore CJ, et al. A randomized, controlled trial of prophylactic granulocyte-macrophage colony-stimulating factor in human newborns less than 32 weeks gestation. Pediatrics 1999;103:796-802.
75. Cairo MS, Agosti J, Ellis R, et al. A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte- macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr 1999;134:64-70.
76. Banerjea MC, Speer CP. The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis. Semin Neonatol 2002;7:335-49.
77. Bernstein HM, Calhoun DA, Christensen RD. Use of myeloid colony-stimulating factors in neonates with septicemia. Curr Opin Pediatr 2002;14:91-4.
78. Parravicini E, van de Ven C, Anderson L, et al. Myeloid hematopoietic growth factors and their role in prevention and/or treatment of neonatal sepsis. Transfus Med Rev 2002;16:11-24.
79. Carr R, Modi N. Haemopoietic colony stimulating factors for preterm neonates. Arch Dis Child Fetal Neonatal Ed 1997;76:F128-33.
80. Bernstein HM, Pollock BH, Calhoun DA, et al. Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: a meta-analysis. J Pediatr 2001;138:917-20.
81. Kuter DJ, Begley CG. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood 2002;100:3457-69.
82. Reynolds CH. Clinical efficacy of rhIL-11. Oncology (Huntingt) 2000;14(9 suppl 8):32-40.
83. Sola MC, Christensen RD, Hutson AD, et al. Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys. Pediatr Res 2000;47:208-14.